These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31922969)

  • 1. Editorial: Refining the role of primary retroperitoneal lymph node dissection in the management of early-stage testicular cancer.
    Daneshmand S
    Curr Opin Urol; 2020 Mar; 30(2):234. PubMed ID: 31922969
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular germ cell tumors: biology and clinical update.
    Mannuel HD; Mitikiri N; Khan M; Hussain A
    Curr Opin Oncol; 2012 May; 24(3):266-71. PubMed ID: 22343384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour.
    Oing C; Rescigno P; Paffenholz P; Heinzelbecker J; Patrikidou A; Matulewicz RS; Huddart R
    Eur Urol Focus; 2024 May; 10(3):361-363. PubMed ID: 39095218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
    Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D; Daneshmand S
    Curr Opin Urol; 2020 Mar; 30(2):251-257. PubMed ID: 31972635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.
    Feldman DR
    Oncology (Williston Park); 2010 Jul; 24(8):761-3. PubMed ID: 20718258
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
    Matulewicz RS; Benfante N; Funt SA; Feldman DR; Carver B; Doudt A; Knezevic A; Sheinfeld J
    J Urol; 2024 Jan; 211(1):80-89. PubMed ID: 37672753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors.
    Daugaard G; Lauritsen J; Bandak M; Agerbæk M; Als AB; Dysager L; Toft BG; Engvad B; Berney DM; Wagner T
    Eur Urol Focus; 2024 May; 10(3):359-360. PubMed ID: 38871631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
    Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C
    J Urol; 2020 Jul; 204(1):96-103. PubMed ID: 32003612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
    Pedraza AM; Stephenson AJ
    Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy.
    Liu J; Thomas B; Lawrentschuk N
    Eur Urol; 2023 Oct; 84(4):438-439. PubMed ID: 37385842
    [No Abstract]   [Full Text] [Related]  

  • 13. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
    Mano R; Di Natale R; Sheinfeld J
    Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comment to: "Primary laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ-cell testis tumor"].
    Alcaraz A
    Actas Urol Esp; 2011 Jan; 35(1):29-30. PubMed ID: 21322830
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Stage IIA-IIC Seminoma: Radiation Therapy versus Systemic Chemotherapy versus Retroperitoneal Lymph Node Dissection.
    von Amsberg G; Hamilton R; Papachristofilou A
    Oncol Res Treat; 2018; 41(6):360-363. PubMed ID: 29763926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional risk of relapse in patients with germ cell testicular tumors: personalizing surveillance in clinical stage 1 disease.
    Goldberg H; Madhur N; Hamilton RJ
    Curr Opin Urol; 2018 Sep; 28(5):454-460. PubMed ID: 29916845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
    Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
    BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there still a place for lymphadenectomy in clinical stage I non-seminoma?
    Weissbach L; Boedefeld EA; Bussar-Maatz R; Kleinschmidt K
    Prog Clin Biol Res; 1988; 269():407-17. PubMed ID: 2839848
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma.
    Seelemeyer F; Pfister D; Pappesch R; Merkelbach-Bruse S; Paffenholz P; Heidenreich A
    Eur Urol Oncol; 2024 Jun; 7(3):319-322. PubMed ID: 37932157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.